Announced

Coloplast to acquire Atos Medical from PAI Partners for $2.5bn.

Synopsis

Coloplast, a medical devices manufacturer, agreed to acquire Atos Medical, a laryngectomy equipment manufacturer and services provider, from PAI Partners, a private equity firm, for $2.5bn. “Atos Medical is an undisputed leader in chronic neck stomas care, and we are well-positioned for long-term growth. Our companies have comparable business models, and the acquisition will enable us to leverage Coloplast’s strengths to serve more people living with a neck stoma even better than today. Coloplast is a world leading medical device company with an impressive track record. I believe our companies are a great match, and I am confident that together we can accelerate our journey to the benefit of our customers worldwide,” Britt Meelby Jensen, Atos Medical CEO.

Principals

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US